This article is the latest in the Health Affairs ... of FDA’s Centers and programs. The proposal reportedly would: Consolidate all current Centers' product review, approval and regulatory ...

The Food and Drug Administration should look for ways to streamline regulations on new U.S. drug manufacturing facilities to ...

Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...

Jeremy Walsh is now heading up artificial intelligence and information technology in a newly created position at the FDA.

Trump's order seeks to ease regulations to compel more U.S. drug manufacturing. He also plans to assess tariffs on drug ...

Advanced Preparation for New Drug Application ~ SAN DIEGO, CA / ACCESS Newswire / May 12, 2025 /Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical ...

The World Vaccine Congress kicks off its annual conference this week in Washington, bringing together researchers, pharma executives and public health officials to discuss the latest vaccine ...

The following year, legislators in the Golden State approved another measure that, starting in 2028, will ban six food dyes — Blue 1, Blue 2, Green 3, Red 40, Yellow 5 and Yellow 6 — from being sold ...

In the US, for example, the FDA now provides the opportunity for ... A strategic partner Regulatory affairs as a function has undergone a significant shift in its strategic role and impact over ...

President Donald Trump signed three extensive orders -- establishing a national center for homeless veterans, reducing ...

Food and Drug Administration Director Martin Makary announced the agency-wide deployment of an artificial intelligence tool to handle the monotonous components of its scientific review process.